Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | ACLY | P53396 | 2/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3367518 | 0.76 | ALDH1A1 (0.38) | ALDH1A1TSHRTP53ACLYTET2 | |
| SCHEMBL8595585 | 0.76 | THRB (0.32) | — | |
| SCHEMBL2125611 | 0.74 | ACLY (0.37) | ALDH1A1TSHRACLYTET2 | |
| SCHEMBL7123847 | 0.72 | TSHR (0.45) | ALDH1A1TSHRACLYTET2 | |
| SCHEMBL28305996 | 0.72 | ACLY (0.37) | ALDH1A1TSHRTP53ACLYTET2 | |
| SCHEMBL1495773 | 0.71 | — | — | |
| SCHEMBL9747113 | 0.70 | ACLY (0.34) | ALDH1A1TSHRACLYTET2 | |
| SCHEMBL259584 | 0.67 | — | — | |
| SCHEMBL557277 | 0.67 | ALDH1A1 (0.40) | ALDH1A1TSHRTP53 | |
| Trichloroacetic Acid SCHEMBL11719563 | 0.65 | ALDH1A1 (0.62) | ALDH1A1TSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108084026-A | A kind of new method of the chlorogenic acid extracting from Cortex Eucommiae | 大兴安岭林格贝寒带生物科技股份有限公司 | 2018-05-29 | — | — | CN | claimed |
| CN-103059069-B | A kind of process of extracting general flavone from wild walking fern | Daxing'an Mountainrange Lin Gebei psychrophile Science and Technology Co., Ltd. (CN) | 2016-05-25 | — | — | CN | claimed |
| CN-103059069-A | Novel technique method for extracting general flavone from wild walking fern | DAXINGANLING LINGONBERRY ORGANIC FOODSTUFFS CO LTD | 2013-04-24 | — | — | CN | claimed |
| CN-117866035-A | Triterpene saponin compound in golden camellia and preparation method thereof | 广西大学 | 2024-04-12 | — | — | CN | disclosed |
| EP-3344622-B1 | GUANIDINE SUBSTITUTED, FUSED 1H-IMIDAZO[4,5-C]PYRIDINE COMPOUNDS USEFUL IN THE TREATMENT OF VIRAL AND NEOPLASTIC DISEASES | 3M INNOVATIVE PROPERTIES CO (US) | 2021-07-07 | — | — | EP | disclosed |
| EP-3344623-B1 | IMIDAZO[4,5-C]RING COMPOUNDS CONTAINING SUBSTITUTED GUANIDINE GROUPS | 3M INNOVATIVE PROPERTIES CO (US) | 2021-02-17 | — | — | EP | disclosed |
| US-10487081-B2 | Guanidine substituted imidazo[4,5-c] ring compounds | 3M INNOVATION PROPERTIES COMPANY (US) | 2019-11-26 | — | — | US | disclosed |
| EP-2397488-B1 | DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS | FEDERAL STATE BUDGETARY INSTITUTION RES ZAKUSOV INSTITUTE OF PHARMACOLOGY (RU) | 2019-03-27 | — | — | EP | disclosed |
| US-20190055241-A1 | GUANIDINE SUBSTITUTED IMIDAZO[4,5-c] RING COMPOUNDS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2019-02-21 | — | — | US | disclosed |
| US-10150768-B2 | Guanidine substituted imidazo[4,5-c] ring compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-12-11 | — | — | US | disclosed |
| US-10118925-B2 | Imidazo[4,5-c] ring compounds containing substituted guanidine groups | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-11-06 | — | — | US | disclosed |
| EP-0171677-B1 | NOVEL ANTHRACYCLINE ANTIBIOTICS | Sanraku Incorporated (JP) | 1988-11-30 | — | — | EP | disclosed |
| EP-0230053-A2 | 7-(Substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids | AMERICAN CYANAMID COMPANY (US) | 1987-07-29 | — | — | EP | disclosed |
| US-4612371-A | Anthracycline antibiotics | SANRAKU INCORPORATED (JP) | 1986-09-16 | — | — | US | disclosed |
| EP-0171677-A1 | Novel anthracycline antibiotics | Sanraku Incorporated (JP) | 1986-02-19 | — | — | EP | disclosed |
| US-4439425-A | IMMUNOLOGY | CIBA-GEIGY CORPORATION (US) | 1984-03-27 | — | — | US | disclosed |
| EP-0026849-B1 | PROCESS FOR PRODUCING ANTHRACYCLINE GLYCOSIDES | SANRAKU-OCEAN CO., LTD. (JP) | 1983-12-07 | — | — | EP | disclosed |
| US-4337312-A | CONVERSION OF AKLAVINONE AND RHODOMYCINONE TO DAUNOMYCIN AND BAUMYCIN ANTIBIOTICS | SANRAKU-OCEAN CO., LTD. (JP) | 1982-06-29 | — | — | US | disclosed |
| EP-0026849-A1 | Process for producing anthracycline glycosides | SANRAKU-OCEAN CO., LTD. (JP) | 1981-04-15 | — | — | EP | disclosed |
| US-4128540-A | Pyroglutamyl-histidyl-tryptophanyl-seryl-tyrosyl hydrazides | PARKE, DAVIS & COMPANY (US) | 1978-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10150768-B2 | Guanidine substituted imidazo[4,5-c] ring compounds | IFNG, IL4, IRF3 | ALDH1A1 2056/4885TSHR 2575/4885TP53 90/4885 |
| US-10487081-B2 | Guanidine substituted imidazo[4,5-c] ring compounds | IFNG, IRF3, IL4 | ALDH1A1 2282/4885TSHR 2622/4885TP53 79/4885 |
| US-10118925-B2 | Imidazo[4,5-c] ring compounds containing substituted guanidine groups | IFNG, IRF3, IL4 | ALDH1A1 2263/4885TSHR 2746/4885TP53 133/4885 |
| US-20190055241-A1 | GUANIDINE SUBSTITUTED IMIDAZO[4,5-c] RING COMPOUNDS | IFNG, IRF3, IL4 | ALDH1A1 2282/4885TSHR 2622/4885TP53 79/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.